<?xml version="1.0"?>
<rss version="2.0" xmlns:prism="http://purl.org/rss/1.0/modules/prism/">
  <channel>
    <title>JAMA: Adrenal Diseases Topic Collection</title>
    <link>http://jama.jamanetwork.com/</link>
    <description>
    </description>
    <language>en-us</language>
    <pubDate>Wed, 13 Jun 2012 00:00:00 GMT</pubDate>
    <lastBuildDate>Tue, 01 Jan 2013 00:43:48 GMT</lastBuildDate>
    <generator>Silverchair</generator>
    <managingEditor>editor@jama.jamanetwork.com</managingEditor>
    <webMaster>webmaster@jama.jamanetwork.com</webMaster>
    <item>
      <title>Cases of Congenital Adrenal Hyperplasia Missed by Newborn Screening in Minnesota</title>
      <link>http://jama.jamanetwork.com/article.aspx?articleID=1182852</link>
      <pubDate>Wed, 13 Jun 2012 00:00:00 GMT</pubDate>
      <author>Sarafoglou K, Banks K, Kyllo J, et al. </author>
      <description>&lt;span class="paragraphSection"&gt;To the Editor: The purpose of newborn screening (NBS) for congenital adrenal hyperplasia (CAH) due to 21α-hydroxylase deficiency is the early identification of newborns with the classic salt-wasting (SW) and simple-virilizing (SV) forms to avoid a potentially life-threatening adrenal or salt-wasting crisis. Cases of classic CAH missed by NBS (false-negatives) are not well documented.&lt;/span&gt;</description>
      <prism:volume xmlns:prism="prism">307</prism:volume>
      <prism:number xmlns:prism="prism">22</prism:number>
      <prism:startingPage xmlns:prism="prism">2371</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">2374</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/jama.2012.5281</prism:doi>
      <guid>http://jama.jamanetwork.com/article.aspx?articleID=1182852</guid>
    </item>
  </channel>
</rss>